By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results…
NEW YORK (Reuters Health) – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease…
Recent Videos in Reuters Health • The Doctor’s Channel Newscast Page 189
NEW YORK (Reuters Health) – Prophylactic antibiotics may improve survival of burn patients, a meta-analysis suggests, although the authors acknowledge that the quality of the supporting data is…
NEW YORK (Reuters Health) – In postmenopausal women with osteoporosis, the selective estrogen-receptor modulator lasofoxifene cuts the risks of fractures, estrogen-receptor-positive breast cancer, coronary disease, and stroke, the…
NEW YORK (Reuters Health) – Baseline platelet function is only modestly related to ischemic outcomes after percutaneous coronary intervention (PCI) in low-risk patients, according to a study in…
NEW YORK (Reuters Health) – In patients with HIV and tuberculosis (TB) whose CD4 cell counts are below 500/mm3, mortality is increased if antiretroviral therapy is delayed until…
NEW YORK (Reuters Health) – During early resuscitation in severe sepsis, lactate clearance can indicate tissue oxygen delivery as effectively as central venous oxygen saturation, with considerably less…
NEW YORK (Reuters Health) – Beta blockade before computed tomographic coronary angiography (CTA) can improve image quality, but a substantial number of patients who require CTA have contraindications…
NEW YORK (Reuters Health) – Survival of extremely premature infants (less than 26 weeks’ gestation) can’t be predicted by appearance at birth and early response to resuscitation, according…
NEW YORK (Reuters Health) – An implantable cardioverter-defibrillator (ICD) should be considered when patients with long QT syndrome (LQTS) have syncope while on beta-blockers. That’s according to authors…
NEW YORK (Reuters Health) – Daclizumab added to ongoing interferon-beta treatment further decreases multiple sclerosis disease activity, according to a multicenter phase II trial reported online February 16…
NEW YORK (Reuters Health) – Intra-partum nevirapine, given to prevent HIV transmission, contributes to HIV resistance mutations to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) – but a one-month postpartum course…
